Advertisement
Table 3 Odds ratio (95 % CI) by direct comparison (left lower part) and network meta- analysis (right upper part) based on safety
| TwHF | 1.21 (0.10–14.26) | 0.19 (0.02–2.07) | 0.11 (0.01–1.36) | 0.66 (0.00–1.64e+28) | 0.35 (0.03–3.74) | 0.36 (0.04–3.85) |
| 0.32 (0.03–3.19) | MTX | 0.16 (0.06–0.40) | 0.09 (0.03–0.31) | 0.55 (0.00–1.31e+28) | 0.29 (0.11–0.73) | 0.30 (0.14–0.68) |
| – | 0.74 (0.49–1.10) | LEF | 0.58 (0.20–1.66) | 3.48 (0.00–8.25e+28) | 1.82 (0.93–3.54) | 1.92 (1.18–3.13) |
| 0.39 (0.16–1.01) | 0.71 (0.40–1.25) | 0.93 (0.51–1.36) | SSZ | 6.02 (0.00–1.43e+29) | 3.15 (1.11–8.91) | 3.33 (1.29–8.33) |
| – | – | 2.06 (0.35–12.06) | – | CsA | 0.52 (0.00–1.27e+33) | 0.55 (0.00–100.0) |
| – | – | – | – | – | FK506 | 1.05 (0.67–1.67) |
| 0.37 (0.01–9.98) | 0.30 (0.14–0.68) | 3.00 (1.87–4.83) | 3.32 (1.30–8.45) | – | 1.03 (0.65–1.61) | Placebo |
